Trivium Point Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.52M Sell
8,686
-844
-9% -$342K 0.38% 68
2025
Q1
$4.74M Sell
9,530
-956
-9% -$476K 0.59% 46
2024
Q4
$5.46M Buy
10,486
+820
+8% +$427K 0.69% 35
2024
Q3
$5.24M Sell
9,666
-768
-7% -$416K 0.73% 36
2024
Q2
$5.77M Buy
10,434
+553
+6% +$306K 0.86% 26
2024
Q1
$5.74M Buy
9,881
+193
+2% +$112K 1.24% 18
2023
Q4
$5.14M Buy
9,688
+158
+2% +$83.9K 1.25% 18
2023
Q3
$4.76M Buy
9,530
+50
+0.5% +$25K 1.31% 15
2023
Q2
$4.95M Sell
9,480
-175
-2% -$91.3K 1.34% 14
2023
Q1
$5.56M Buy
9,655
+155
+2% +$89.3K 1.5% 14
2022
Q4
$5.08M Buy
9,500
+103
+1% +$55.1K 1.48% 12
2022
Q3
$5.08M Buy
9,397
+219
+2% +$118K 1.58% 10
2022
Q2
$5.08M Sell
9,178
-7
-0.1% -$3.88K 1.53% 13
2022
Q1
$5.4M Buy
9,185
+270
+3% +$159K 1.2% 19
2021
Q4
$5.95M Buy
8,915
+110
+1% +$73.4K 1.25% 16
2021
Q3
$5.14M Sell
8,805
-45
-0.5% -$26.3K 1.22% 16
2021
Q2
$4.47M Buy
8,850
+336
+4% +$170K 1.11% 19
2021
Q1
$3.89M Sell
8,514
-148
-2% -$67.6K 1.05% 14
2020
Q4
$4.33M Sell
8,662
-177
-2% -$88.6K 1.25% 12
2020
Q3
$3.9M Buy
8,839
+337
+4% +$149K 1.38% 11
2020
Q2
$3.25M Buy
8,502
+576
+7% +$220K 1.29% 13
2020
Q1
$2.43M Sell
7,926
-506
-6% -$155K 1.25% 14
2019
Q4
$2.74M Buy
8,432
+60
+0.7% +$19.5K 1.06% 15
2019
Q3
$2.32M Sell
8,372
-325
-4% -$89.9K 1.06% 20
2019
Q2
$2.55M Buy
8,697
+375
+5% +$110K 1.14% 14
2019
Q1
$2.28M Sell
8,322
-20
-0.2% -$5.48K 1.06% 17
2018
Q4
$1.87M Buy
+8,342
New +$1.87M 1.13% 24